BIOTECH ACQUISITION COMPANY's ticker is BIOTW and the CUSIP is G1125A116. A total of 56 filers reported holding BIOTECH ACQUISITION COMPANY in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $29,654 | +5.9% | 464,062 | 0.0% | 0.01% | +28.6% |
| Q3 2022 | $28,000 | -33.3% | 464,062 | 0.0% | 0.01% | -30.0% |
| Q2 2022 | $42,000 | -62.2% | 464,062 | 0.0% | 0.01% | -47.4% |
| Q1 2022 | $111,000 | -63.7% | 464,062 | 0.0% | 0.02% | -64.2% |
| Q4 2021 | $306,000 | 0.0% | 464,062 | 0.0% | 0.05% | -10.2% |
| Q3 2021 | $306,000 | -23.3% | 464,062 | 0.0% | 0.06% | -28.9% |
| Q2 2021 | $399,000 | +7.5% | 464,062 | -25.0% | 0.08% | -4.6% |
| Q1 2021 | $371,000 | – | 618,749 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RAMIUS ADVISORS LLC | 501,826 | $432,000 | 0.16% |
| Kingstown Capital | 300,000 | $258,000 | 0.15% |
| Telemetry Investments, L.L.C. | 85,000 | $73,000 | 0.10% |
| Corbin Capital Partners, L.P. | 464,062 | $399,000 | 0.08% |
| Atalaya Capital Management LP | 278,437 | $239,000 | 0.06% |
| Radcliffe Capital Management, L.P. | 202,950 | $1,963,000 | 0.06% |
| Kamunting Street Capital Management, L.P. | 158,962 | $137,000 | 0.06% |
| DG Capital Management, LLC | 224,999 | $193,000 | 0.04% |
| MMCAP International Inc. SPC | 300,000 | $258,000 | 0.01% |
| PERISCOPE CAPITAL INC. | 248,300 | $213,000 | 0.01% |